Trials / Completed
CompletedNCT04436822
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 317 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 2 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Detailed description
The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days). This is a multi-center study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitoring | CGM and frequent sample testing |
Timeline
- Start date
- 2020-07-15
- Primary completion
- 2022-04-12
- Completion
- 2022-04-12
- First posted
- 2020-06-18
- Last updated
- 2023-06-02
- Results posted
- 2023-06-02
Locations
18 sites across 2 countries: United States, China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04436822. Inclusion in this directory is not an endorsement.